UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korean biosimilars rarely prescribed in US
Korean biosimilar products are still struggling to penetrate the U.S. marke...
by So Jae-hyeon
|
2018-04-05 15:05
라인
Arrest of doctors over infants’ deaths stirs controversy
Two physicians and one nurse were arrested Wednesday over the deaths of fou...
by Choi Gwang-seok
|
2018-04-04 16:34
라인
HanAll wins patent for monoclonal antibody in Taiwan
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo
|
2018-04-04 16:07
라인
Will SGLT-2 combos with DPP-4 win insurance coverage?
Suppliers of antidiabetic medicines are paying attention to whether SGLT-2 ...
by So Jae-hyeon
|
2018-04-04 15:12
라인
Filler study plans won the most approvals in 2017
Medical device manufacturers’ plans for clinical trials on filler developme...
by Lee Hye-seon
|
2018-04-04 14:55
라인
SMC surgeons complete 4,000 microvascular decompressions
Doctors from Samsung Medical Center recently completed the hospital’s 4,000...
by Marian Chu
|
2018-04-04 14:54
라인
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam
CTC Bio said Tuesday that it has acquired marketing approval for its erecti...
by Lee Han-soo
|
2018-04-04 10:59
라인
Survey finds Koreans suffering from loneliness
Korea is suffering from a loneliness epidemic.Based on a survey conducted b...
by Lee Han-soo
|
2018-04-03 17:00
라인
Outpatient drug prescriptions plunged in February
The outpatient drug prescriptions market saw a drastic contraction in Febru...
by So Jae-hyeon
|
2018-04-03 16:59
라인
Sanofi Genzyme Korea gets go-ahead to market Dupixent
Sanofi Genzyme Korea, the specialty care division of the French pharmaceuti...
by Marian Chu
|
2018-04-03 15:23
라인
Ildong wins patent for retinal diseases biobetter treatment
Ildong Pharmaceutical said Monday that it has acquired a patent regarding t...
by Lee Han-soo
|
2018-04-03 14:35
라인
Heart transplant recipient gives birth for 1st time in Korea
A heart transplant recipient gave birth to a baby for the first time in Kor...
by Kwak Sung-sun
|
2018-04-03 14:35
라인
St. Mary’s professors find link between atopic dermatitis and FLG mutation
Researchers from the Catholic University of Korea Seoul St. Mary’s Hospital...
by Marian Chu
|
2018-04-03 11:59
라인
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon
|
2018-04-03 11:58
라인
Seoul orders Janssen to fill up PMS cases to 3,000
Janssen Korea will have to increase the number of post-marketing surveillan...
by Lee Hye-seon
|
2018-04-02 16:30
라인
Boehringer Ingelheim’s COPD therapy may reduce exacerbation risk
Boehringer Ingelheim Korea said Monday that findings from a study of its ch...
by Marian Chu
|
2018-04-02 15:14
라인
[Feature] Peer support helps mental patients recover
A local mental hospital has adopted a training program to nurture “peer sup...
by Yang Geum-deok
|
2018-04-02 15:11
라인
Chinese lab ends Olita deal with Hanmi
China’s biotech firm Zai Lab has returned the exclusive sales license of an...
by So Jae-hyeon
|
2018-04-02 11:39
라인
National Cancer Center to open hospice facility by 2020
The National Cancer Center (NCC) said that it would complete the constructi...
by Marian Chu
|
2018-04-02 11:37
라인
NCC transfers cancer cell line to Canadian firm
The National Cancer Center said Wednesday it has signed a materials transfe...
by Marian Chu
|
2018-04-02 11:37
-
이전
221
222
223
224
225
226
227
228
229
230
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top